Infraredx Inc, a medical device company, announced it has received a $25 million equity investment from Nipro Corp. This investment builds on Infraredx’s exclusive agreement with Nipro for distribution of its TVC Imaging System in Japan. In conjunction with the investment, a member of Nipro’s management team will join Infraredx’s board of directors.
The TVC Imaging System is an intravascular imaging system that integrates near infrared spectroscopy (NIRS) lipid core plaque (LCP) detection and enhanced intravascular ultrasound (IVUS) imaging technology to assess vessel composition and structure.
Proceeds from this investment will be used to support Infraredx’s expansion, operations, and the commercialization of the TVC Imaging System in Japan. The companies are on track to receive Japanese regulatory approval of the TVC Imaging System in the first half of 2014.
